There have been many studies on the antitumoral effect of D-amygdalin (D-mandelonitrile-b-D-gentiobioside), generally known as Laetrile. [1] [2] [3] It was reported that D-amygalin in aqueous solution is racemized to neoamygdalin (L-mandelonitrile-b-D-gentiobioside), making it ineffective against cancer.
1 H-NMR spectra were recorded by using a Bruker Avance-600 (600 MHz) NMR spectrometer and FAB-HR spectra were recorded using a JMS-AX505WA mass spectrometer.
Sample Preparation Neoamygdalin was prepared from D-amygdalin and aqueous ammonia as described by Fischer. 10) D-Amygdalin was added to 10 ml of 0.005 M ammonia solution and the mixture was stored for 2 h at room temperature. During this period, D-L isomerization occured and equilibrium between D-amygdalin and neoamygdalin was achived.
Neoamygdalin was purified by HPLC (Nucleosil 100-5 C18, 250 mmϫ10 mm i.d.; mobile phase, 6% acetonitrile; flow rate, 5 ml/min; column temperature, ambient) and characterized by FAB-HR mass and 1 H-NMR (CD 3 OD) spectroscopy. 6 Solutions containing amygdalin (0.6 mg/ml) in distilled water were prepared and heated at 100°C for 3, 30, and 120 min. Solutions containing amygdalin (0.6 mg/ml) in 0.001% citric acid (measured pH of the solution: 5.9) and 0.05% citric acid (pH 4.3) were prepared and heated at 100°C for 120 min. Samples of Tōnin (Persicae Semen) containing 0.001% citric acid, 0.05% citric acid, and 0.1% citric acid were prepared and heated at 100°C for 120 min under reflux.
Results and Discussion
Separation of D-Amygdalin and Neoamygdalin The conditions of the mobile phase to separate D-amygdalin and neoamygdalin by reverse-phase HPLC were examined in 10 mM sodium phosphate buffer (pH 3.8) containing 1-butanol or acetonitrile. Complete baseline resolution was obtained using phosphate buffer containing 0.3% 1-butanol, but it had the shortcoming of requiring 135 min for separation (Fig.  1a) . The separation time became shorter by increasing the concentration of 1-butanol, but baseline resolution was not obtained.
When phosphate buffer containing 6% acetonitrile was used instead of 1-butanol, baseline resolution was obtained and the separation time was shortened to 45 min (Fig. 1b) . Therefore it appeared that 10 mM sodium phosphate buffer (pH 3.8) containing 6% acetonitrile was a suitable mobile phase and it was used it for the separation of D-amygdalin and neoamygdalin. The calibration plots were drawn and showed a linear range of the UV response to the concentration (0.05 to 0.5 mM) of D-amygdalin and neoamygdalin (r 2 values were 0.9998 for D-amygdalin and 0.9994 for neoamygdalin).
The detection limits were within 5 mM (S/Nϭ3).
Racemization of D-Amygdalin by Heating
We investigated the degree of conversion of D-amygdalin to neoamygdalin with the addition of boiling water. As shown in Fig. 2 , D-amygdalin started to convert to neoamygdalin 3min after heating. About 30% and more than 50% of D-amygdalin, respectively, were converted to neoamygdalin 30 and 120 min after heating reaction. It was found that D-amygdalin in aqueous solution was converted to neoamygdalin by heating alone. Because only D-amygdalin is effective against cancer, it was necessary to determine the conditions for inhibition of its conversion to neoamygdalin.
Inhibition of the Conversion of D-Amygdalin to Neoamygdalin with Citric Acid Citric acid and ascorbic acid were examined to investigate whether they could inhibit the conversion of D-amygdalin to neoamygdalin. Citric acid, but not ascorbic acid, completely inhibited racemization. We examined the extent of the conversion to neoamygdalin in 0.001-0.5% citric acid solution at 100°C for 2 h. Figure 3 shows the results of 0.001% and 0.05% citric acid solution. Although the conversion rate was more than 50% in 0.001% citric acid solution (pH 5.9), the conversion rate to neoamygdalin in 0.05% citric acid solution (pH 4.3) were almost 0%. Therefore 0.05-0.5% citric acid solution prevent the conversion and glycolysis of D-amygdalin. Application to Natural Products In this study, we established methods to separate D-amygdalin and neoamygdalin and to inhibit racemization. We applied these methods to the extraction process of D-amygdalin from Tōnin (Persicae Semen), which is widely used in Oriental preparations. Figure 4 shows the inhibitory effects on the conversion to neoamygdalin with the percentage concentration of citric acid. The conversion rate to neoamygdalin in 0.005% citric acid solution (pH 5.7) and 0.05% citric acid solution (pH 4.7) was about 20% and 10%, respectively.
In 0.05% citric acid solution, racemization of standard amygdalin was completely inhibited, but that of the amygdalin in Tōnin was not completely inhibited because of the increase in pH due to various other constituents in Tōnin. The conversion rate to neoamygdalin in 0.1% citric acid solution (pH 2.9) was almost 0%. About one-tenth of D-amygdalin is in the form of neoamygdalin as shown in Fig. 4c 
